Laser therapy offers hope for cancer survivors with menopause symptoms

NCT ID NCT07420647

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a non-hormonal laser treatment for genitourinary syndrome of menopause (GSM) in women who have completed cancer treatment. GSM causes symptoms like vaginal dryness and pain, which can affect quality of life. The study will compare the laser therapy to a control group in 65 women, using questionnaires and exams to see if symptoms improve.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Non-ablative vaginal Er:YAG laser therapy
What this could lead to
If this works, it could offer a safe, non-hormonal option to ease vaginal dryness and pain for women who have had cancer treatment.
What could go wrong
This is a small pilot study with only 65 participants, so results may not apply to everyone. The laser therapy is still experimental and may not work for all women.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FEMALE CANCER SURVIVORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Institute of Oncology Ljubljana

    Ljubljana, 1000, Slovenia

More trials for these conditions

Other studies related to the condition(s) this trial covers.